MRKR Marker Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ 10-K/10-Q Aug 14, 2026
$0.96
· of 52w range
· above low
· to high
$0.8452w low
$2.3252w high
Market Cap (MRQ)
$16M
P/E
-1.2
EPS
$-0.79
Revenue
$4M
your badges
52W Range
$1–$2
Analyst Rating
BUY
Price Target
$8
P/E
-1.2
ROE
-89.1%
Net Profit Margin
-343.0%
Your badge strip is empty — pin a metric anywhere on this page.
MRKR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.96
Market Cap (MRQ)
$16M
P/E
-1.2
EPS
$-0.79
Revenue
$4M
ROE
-89.1%
52W Range
$1–$2
MRKR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Jan. 27, 2023 | 1-for-10 | Reverse |
| Sept. 16, 2016 | 1-for-12 | Reverse |
| Feb. 25, 2014 | 1-for-100 | Reverse |
| July 27, 2009 | 1-for-10 | Reverse |
| June 28, 2007 | 1-for-2 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$4M2017-12-31 → 2025-12-31
EPS$-0.792016-12-31 → 2025-12-31
Free Cash Flow·2018-12-31 → 2019-12-31
Net margin-343.0%2018-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | MRKR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -1.25Y avg ≈-2.6 | ≈-2.6 | · | · | |
| P/S | 4.55Y avg ≈133.8 | ≈133.8 | 8.6 | Undervalued | |
| P/B (MRQ) | 1.35Y avg ≈5.2 | ≈5.2 | 2.0 | Fair value | |
| Price / Cash Flow | -1.35Y avg ≈-7.6 | ≈-7.6 | · | · | |
| Price / Tangible Book | 1.05Y avg ≈5.2 | ≈5.2 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | MRKR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | -363.4%5Y avg ≈-326.2% | ≈-326.2% | -541.8% | In line | |
| EBITDA Margin | -363.4%5Y avg ≈-318.4% | ≈-318.4% | -541.8% | In line | |
| Pretax Margin | -343.4%5Y avg ≈-309.8% | ≈-309.8% | -984.9% | Top tier | |
| Net Profit Margin | -343.0%5Y avg ≈-271.6% | ≈-271.6% | -812.4% | Top tier | |
| ROA | -59.2%5Y avg ≈-55.6% | ≈-55.6% | -46.9% | Weak | |
| ROE | -89.1%5Y avg ≈-90.8% | ≈-90.8% | -89.1% | In line | |
| ROIC | -76.6%5Y avg ≈-80.2% | ≈-80.2% | -61.8% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | MRKR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 6.05Y avg ≈5.2 | ≈5.2 | 2.5 | Strong liquidity | |
| Quick Ratio | 7.15Y avg ≈4.5 | ≈4.5 | 1.5 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | MRKR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -46.2%5Y avg ≈75.7% | ≈75.7% | · | · | |
| Revenue CAGR 3Y | 0.31%5Y avg ≈54.2% | ≈54.2% | · | · | |
| Revenue CAGR 5Y | 48.0% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | MRKR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.25Y avg ≈0.2 | ≈0.2 | 0.0 | Top tier | |
| Revenue / Employee | ≈$709.3K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
24.8%
Next Report
Nov 11, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 14, 2026 | $-0.09 | $-0.22 | 59.3% |
| March 31, 2026 | May 15, 2026 | $-0.16 | $-0.19 | 14.4% |
| Dec. 31, 2025 | $-0.09 | $-0.20 | 55.1% | |
| Sept. 30, 2025 | $-0.12 | $-0.46 | 73.9% | |
| June 30, 2025 | $-0.29 | $-0.42 | 30.7% | |
| March 31, 2025 | $-0.36 | $-0.50 | 28.0% | |
| Dec. 31, 2024 | $-0.42 | $-0.22 | -87.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $7M | $3M | $4M | $1M | $500.0K | $213.2K | $206.0K | $183.1K | |
| R&D Expense | $12M | $13M | $10M | $12M | $28M | $19M | $13M | $8M | $5M | |
| SG&A Expense | $4M | $4M | $7M | $11M | $13M | $10M | $10M | $24M | $6M | |
| Operating Expenses | $16M | $18M | $18M | $23M | $41M | $29M | $23M | $148M | $12M | |
| Operating Income | $-13M | $-11M | $-15M | $-20M | $-39M | $-29M | $-23M | $-148M | $-11M | |
| Interest Income | $594.2K | $437.0K | $539.2K | $248.1K | $5.7K | $148.7K | $1M | $253.7K | $0 | |
| Pretax Income | $-12M | $-11M | $-14M | $-20M | · | · | · | · | · | |
| Income Tax | $-15.2K | $50.0K | $3.7K | · | · | · | · | $0 | $0 | |
| Net Income | $-12M | $-11M | $-8M | $-30M | $-42M | $-29M | $-21M | $-148M | $-11M | |
| EPS (Basic) | $-0.79 | $-1.19 | $-0.94 | $-3.58 | $-5.47 | $-0.61 | · | · | $-1.16 | |
| EPS (Diluted) | $-0.79 | $-1.19 | $-0.94 | $-3.58 | $-5.47 | $-0.61 | · | · | $-1.16 | |
| Shares (Basic) | 15,310,308 | 8,980,207 | 8,809,382 | 8,351,003 | 7,650,567 | 47,039,862 | 45,587,734 | 19,091,926 | 9,453,483 | |
| Shares (Diluted) | 15,310,308 | 8,980,207 | 8,809,382 | 8,351,003 | 7,650,567 | 47,039,862 | · | · | 9,453,483 | |
| EBITDA | $-13M | $-11M | $-15M | $-27M | $-37M | $-28M | $-22M | $-148M | $-12M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $19M | $15M | $12M | $42M | $21M | $44M | $62M | $5M | |
| Prepaid Expense | $658.8K | $483.7K | $988.1K | $2M | $2M | $2M | $2M | $141.7K | $51.1K | |
| Other Current Assets | · | $2.0K | · | · | · | · | · | · | · | |
| Current Assets | $19M | $22M | $17M | $17M | $46M | $24M | $45M | $62M | $5M | |
| PP&E (Net) | · | · | · | $12M | $12M | $10M | $418.0K | $147.7K | $0 | |
| PP&E (Gross) | · | · | · | $18M | $13M | $4M | $523.0K | $148.0K | $0 | |
| Accum. Depreciation | · | · | · | $5M | $3M | $591.0K | $105.0K | $0 | $0 | |
| Total Assets | $19M | $22M | $17M | $34M | $68M | $46M | $46M | $62M | $5M | |
| Accounts Payable | $793.7K | $1M | $961.0K | $1M | $5M | $3M | $993.0K | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | · | $5.0K | |
| Current Liabilities | $2M | $3M | $3M | $8M | $13M | $6M | $2M | $3M | $2M | |
| Capital Leases | · | · | · | $7M | $11M | $12M | $280.2K | $0 | · | |
| Total Liabilities | $2M | $3M | $3M | $15M | $24M | $18M | $2M | $3M | $2M | |
| Total Debt | · | · | · | · | · | · | · | · | $5.0K | |
| Common Stock | $16.7K | $10.7K | $8.9K | $8.4K | $8.3K | $50.7K | $45.7K | $45.4K | $10.6K | |
| Paid-in Capital | $476M | $466M | $450M | $448M | $442M | $384M | $372M | $365M | $161M | |
| Retained Earnings | $-459M | $-447M | $-436M | $-428M | $-398M | $-356M | $-328M | $-306M | $-157M | |
| Stockholders' Equity | $17M | $19M | $14M | $20M | $44M | $27M | $44M | $59M | $4M | |
| Liabilities + Equity | $19M | $22M | $17M | $34M | $68M | $46M | $46M | $62M | $5M | |
| Shares Outstanding | 16,700,000 | 10,700,000 | 8,900,000 | 8,400,000 | 8,300,000 | 50,700,000 | 45,700,000 | 45,400,000 | 10,600,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $3M | $2M | $485.6K | $105.1K | · | · | |
| Stock-based Comp | $537.5K | $245.9K | $858.3K | $3M | $6M | $5M | $5M | $16M | $3M | |
| Other Non-cash | · | · | · | $-5M | $6M | $4M | $-2M | · | · | |
| Operating Cash Flow | $-12M | $-11M | $-16M | $-27M | $-27M | $-20M | $-18M | $-14M | $-8M | |
| CapEx | · | · | · | · | · | · | $375.0K | $147.7K | $0 | |
| Investing Cash Flow | · | · | $19M | $-5M | $-3M | $-9M | $-375.0K | $-147.7K | $0 | |
| Stock Issued | $10M | $15M | $1M | $202.1K | $53M | $6M | $0 | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | $71.7K | $310.5K | |
| Net Stock Activity | $10M | · | $1M | $202.1K | $53M | $6M | · | $-71.7K | $-310.5K | |
| Financing Cash Flow | $10M | $15M | $1M | $202.1K | $53M | $7M | $816.5K | $71M | $6M | |
| Net Change in Cash | · | · | · | $12M | $44M | · | · | · | · | |
| Taxes Paid | $42.0K | $72.2K | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | $-19M | $-15M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -363.4% | -168.7% | -440.4% | -332.2% | · | -6188.2% | -10567.3% | -71930.1% | · | |
| Net Margin | -343.0% | -162.8% | -248.8% | -332.1% | · | -6149.7% | -10050.9% | -71826.3% | · | |
| Pretax Margin | -343.4% | -162.1% | -424.1% | · | · | · | · | · | · | |
| EBITDA Margin | -363.4% | -168.7% | -440.4% | -301.3% | · | -6084.2% | -10518.0% | -71930.1% | · | |
| ROA | -59.2% | -54.8% | -32.0% | -58.4% | -73.6% | -62.4% | -39.5% | -439.5% | -167.6% | |
| ROE | -89.1% | -82.5% | -53.6% | -141.8% | -87.0% | -99.1% | -46.6% | -492.9% | -223.2% | |
| ROIC | -76.6% | -60.2% | -103.8% | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 6.4 | 5.6 | 2.1 | 3.6 | 3.8 | 22.8 | 22.1 | 3.4 | |
| Quick Ratio | 7.1 | 5.5 | 4.9 | 1.5 | 3.3 | 3.3 | 22.0 | 22.0 | 3.4 | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.0 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.01 | $1.73 | $1.58 | $2.33 | $0.53 | $0.54 | $0.96 | $1.31 | $0.35 | |
| Revenue / Share | $0.23 | $0.73 | $0.38 | $1.08 | $0.00 | · | · | · | · | |
| Cash Flow / Share | $-0.78 | $-1.21 | $-1.87 | $-3.23 | $-0.36 | · | · | · | $-0.89 | |
| Cash / Share | $0.96 | $1.79 | $1.70 | $1.40 | $0.51 | $0.42 | $0.96 | $1.36 | $0.48 | |
| EPS (TTM) | $-0.79 | $-1.19 | $-0.94 | $-3.58 | $-5.47 | $-0.61 | · | · | $-1.16 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -46.2% | 99.1% | -5.8% | 183.0% | 148.3% | · | · | · | · | |
| Revenue CAGR 3Y | 0.31% | 74.4% | 87.8% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 48.0% | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $7M | $3M | $4M | $1M | $500.0K | $213.2K | $206.0K | $183.1K | |
| Net Income TTM | $-12M | $-11M | $-8M | $-30M | $-42M | $-29M | $-21M | $-148M | $-11M | |
| Market Cap | $25M | $33M | $49M | $23M | $789M | $735M | $1.32B | $2.52B | $416M | |
| Enterprise Value | · | · | · | · | · | · | · | · | $410M | |
| P/E | -1.9 | -2.6 | -5.9 | -0.8 | -1.7 | -23.8 | · | · | -33.8 | |
| P/S | 7.0 | 5.0 | 14.8 | 6.5 | 635.8 | 1470.3 | 6173.5 | 12231.9 | 2269.8 | |
| P/B | 1.5 | 1.8 | 3.5 | 1.2 | 17.9 | 26.9 | 29.9 | 42.5 | 113.6 | |
| P / Tangible Book | 1.5 | 1.8 | 3.5 | 1.2 | 17.9 | 26.9 | · | · | · | |
| P / Cash Flow | -2.1 | -3.0 | -3.0 | -0.8 | -28.9 | -39.0 | -72.0 | -174.0 | -49.2 | |
| P / FCF | · | · | · | · | · | · | -70.5 | -172.3 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | -35.2 | |
| EV / Revenue | · | · | · | · | · | · | · | · | 2241.8 | |
| Earnings Yield | -53.0% | -38.3% | -17.1% | -132.6% | -57.6% | -4.2% | · | · | -3.0% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $751.7K | $1M | $1M | $861.2K | $349.1K | $2M | $2M | $1M | $1M | $1M | $257.6K | $762.7K | $1M | $759.1K | $999.6K | |
| R&D Expense | $1M | $3M | $2M | $2M | $4M | $3M | $5M | $3M | $2M | $3M | $3M | $2M | $2M | $3M | $-2M | $4M | |
| SG&A Expense | $1M | $1M | $846.6K | $1M | $945.2K | $1M | $1M | $854.7K | $1M | $1M | $1M | $1M | $3M | $2M | $1M | $3M | |
| Operating Expenses | $3M | $4M | $3M | $3M | $5M | $5M | $6M | $4M | $3M | $4M | $4M | $3M | $5M | $6M | $-339.6K | $7M | |
| Operating Income | $-3M | $-4M | $-2M | $-2M | $-5M | $-5M | $-4M | $-2M | $-2M | $-3M | $-3M | $-3M | $-4M | $-4M | $1M | $-6M | |
| Interest Income | $112.6K | $132.9K | $165.6K | $138.1K | $128.0K | $162.5K | $73.7K | $91.7K | $115.4K | $156.2K | $201.3K | $218.1K | $35.1K | $84.7K | $109.4K | $99.8K | |
| Net Income | $-2M | $-3M | $-2M | $-2M | $-4M | $-4M | $-4M | $-2M | $-2M | $-2M | $-3M | $-3M | $3M | $-5M | $-4M | $-7M | |
| EPS (Basic) | $-0.09 | $-0.16 | $0.02 | $-0.12 | $-0.29 | $-0.40 | $-0.41 | $-0.26 | $-0.25 | $-0.27 | $-0.32 | $-0.34 | $0.29 | $-0.57 | $-0.45 | $-0.83 | |
| EPS (Diluted) | $-0.09 | $-0.16 | $0.02 | $-0.12 | $-0.29 | $-0.40 | $-0.41 | $-0.26 | $-0.25 | $-0.27 | $-0.32 | $-0.34 | $0.29 | $-0.57 | $-0.45 | $-0.83 | |
| Shares (Basic) | 19,314,742 | 19,314,742 | · | 16,757,678 | 13,956,562 | 11,106,027 | · | 8,923,170 | 8,918,233 | 8,901,962 | · | 8,825,881 | 8,798,956 | 8,721,031 | · | 8,359,920 | |
| Shares (Diluted) | 19,314,742 | 19,314,742 | · | 16,757,678 | 13,956,562 | 11,106,027 | · | 8,923,170 | 8,918,233 | 8,901,962 | · | 8,825,881 | 8,798,956 | 8,721,031 | · | 8,359,920 | |
| EBITDA | $-3M | $-4M | · | $-2M | $-4M | $-5M | · | $-2M | $-2M | $-3M | · | $-3M | $-4M | $-4M | · | $-7M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $15M | $16M | $18M | $10M | $14M | $19M | $9M | $8M | $11M | $15M | $17M | $18M | $6M | $12M | $18M | |
| Prepaid Expense | $1M | $418.1K | · | · | · | $841.3K | · | $1M | $1M | $917.0K | $988.1K | $2M | $2M | $2M | $2M | $3M | |
| Other Current Assets | $7.2K | $13.2K | · | · | · | · | $2.0K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $15M | $17M | $19M | $22M | $15M | $17M | $22M | $11M | $12M | $14M | $17M | $19M | $22M | $11M | $17M | $22M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $12M | · | $13M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $18M | · | $18M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | · | $5M | |
| Total Assets | $15M | $17M | $19M | $22M | $15M | $17M | $22M | $11M | $12M | $14M | $17M | $19M | $22M | $28M | $34M | $41M | |
| Accounts Payable | $585.0K | $2M | $793.7K | $951.0K | $2M | $1M | $1M | $2M | $1M | $1M | $961.0K | $1M | $1M | $3M | $1M | $2M | |
| Current Liabilities | $2M | $4M | $2M | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $5M | $8M | $11M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | $7M | · | $7M | |
| Total Liabilities | $2M | $4M | $2M | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $12M | $15M | $19M | |
| Common Stock | $16.7K | $16.7K | $16.7K | $16.7K | $11.3K | $11.2K | $10.7K | $8.9K | $8.9K | $8.9K | $8.9K | $8.9K | $8.8K | $8.8K | $8.4K | $83.6K | |
| Paid-in Capital | $476M | $476M | $476M | $476M | $466M | $466M | $466M | $451M | $451M | $450M | $450M | $450M | $450M | $449M | $448M | $447M | |
| Retained Earnings | $-464M | $-462M | $-459M | $-457M | $-455M | $-451M | $-447M | $-443M | $-441M | $-439M | $-436M | $-433M | $-431M | $-433M | $-428M | $-424M | |
| Stockholders' Equity | $12M | $14M | $17M | $18M | $10M | $14M | $19M | $7M | $10M | $12M | $14M | $17M | $19M | $16M | $20M | $23M | |
| Liabilities + Equity | $15M | $17M | $19M | $22M | $15M | $17M | $22M | $11M | $12M | $14M | $17M | $19M | $22M | $28M | $34M | $41M | |
| Shares Outstanding | 16,700,000 | 16,700,000 | 16,700,000 | 16,700,000 | 11,300,000 | 11,200,000 | 10,700,000 | 8,900,000 | 8,900,000 | 8,900,000 | 8,900,000 | 8,800,000 | 8,800,000 | 8,800,000 | 8,400,000 | 83,600,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | · | · | $818.2K | · | $819.9K | |
| Stock-based Comp | $195.7K | $178.4K | $111.1K | $33.3K | $14.0K | $379.1K | $50.5K | $53.3K | $62.6K | $79.4K | $143.4K | $175.0K | $-120.1K | $659.9K | $382.9K | $-210.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-4M | $-1M | $-2M | $-3M | $-2M | $-5M | $-5M | $1M | $-4M | $-4M | $-2M | $-1M | $-7M | $-6M | $-6M | $-8M | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $19M | $-112.6K | $-127.3K | $-99.4K | |
| Stock Issued | · | · | $0 | · | · | · | $15M | $0 | · | · | · | $394.7K | $0 | $620.0K | $138.6K | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $620.0K | · | · | |
| Financing Cash Flow | · | · | $0 | $10M | $100 | $505 | $15M | $1.7K | $44.6K | $49.1K | $5.1K | $479.3K | $736 | $620.0K | $138.6K | $0 |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -541.8% | · | -173.3% | -494.8% | -1320.1% | · | -124.6% | -197.4% | -204.9% | · | -1242.2% | -542.1% | -106.7% | · | -177.7% | |
| Net Margin | · | -422.9% | · | -162.1% | -466.3% | -1273.6% | · | -119.8% | -187.5% | -192.3% | · | -1157.6% | 329.9% | -104.9% | · | -175.2% | |
| EBITDA Margin | · | -541.8% | · | -173.3% | -494.8% | -1320.1% | · | -124.6% | -197.4% | -204.9% | · | -1242.2% | -542.1% | -89.4% | · | -177.7% | |
| ROA | -12.4% | -18.5% | · | -12.2% | -30.4% | -28.6% | · | -15.2% | -13.0% | -11.4% | · | -9.8% | 6.8% | -12.0% | · | -12.2% | |
| ROE | -16.1% | -22.5% | · | -15.5% | -39.8% | -33.8% | · | -19.1% | -15.3% | -17.3% | · | -15.2% | 10.7% | -19.2% | · | -18.5% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 4.8 | · | 6.5 | 3.5 | 6.8 | · | 3.2 | 5.9 | 6.1 | · | 7.0 | 7.5 | 2.1 | · | 2.0 | |
| Quick Ratio | 4.7 | 4.1 | · | 5.3 | 2.4 | 5.5 | · | 2.6 | 4.0 | 4.9 | · | 6.3 | 6.2 | 1.2 | · | 1.6 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.1 | · | 0.1 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.73 | $0.83 | · | $1.10 | $0.93 | $1.29 | · | $0.84 | $1.09 | $1.32 | · | $1.90 | $2.16 | $1.81 | · | $0.27 | |
| Revenue / Share | · | $0.04 | · | $0.07 | $0.06 | $0.03 | · | $0.22 | $0.13 | $0.14 | · | $0.03 | $0.09 | $0.54 | · | $0.05 | |
| Cash Flow / Share | · | $-0.07 | · | · | · | $-0.50 | · | · | · | $-0.43 | · | · | · | $-0.68 | · | · | |
| Cash / Share | $0.68 | $0.89 | · | $1.05 | $0.93 | $1.22 | · | $1.01 | $0.88 | $1.27 | · | $1.99 | $2.06 | $0.73 | · | $0.22 | |
| EPS (TTM) | $-0.35 | $-0.55 | · | $-1.22 | $-1.36 | $-1.32 | · | $-1.10 | $-1.18 | $-0.64 | · | $-1.07 | $-1.56 | $-2.96 | · | $-8.16 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | · | $5M | $5M | $6M | · | $5M | $4M | $3M | · | $3M | $4M | $4M | · | · | |
| Net Income TTM | $-9M | $-11M | · | $-14M | $-15M | $-13M | · | $-10M | $-10M | $-6M | · | $-9M | $-13M | $-25M | · | $-36M | |
| Market Cap | $25M | $22M | · | $15M | $17M | $14M | · | $25M | $48M | $38M | · | $40M | $27M | $6M | · | $309M | |
| P/E | -4.2 | -2.4 | · | -0.7 | -1.1 | -0.9 | · | -2.6 | -4.6 | -6.7 | · | -4.2 | -2.0 | -0.2 | · | -0.5 | |
| P/S | 6.2 | 5.5 | · | 3.2 | 3.2 | 2.4 | · | 4.7 | 13.0 | 11.5 | · | 13.3 | 7.3 | 1.7 | · | · | |
| P/B | 2.0 | 1.6 | · | 0.8 | 1.6 | 1.0 | · | 3.4 | 5.0 | 3.2 | · | 2.4 | 1.4 | 0.4 | · | 13.7 | |
| P / Tangible Book | 2.0 | 1.6 | · | 0.8 | 1.6 | 1.0 | · | 3.4 | 5.0 | 3.2 | · | 2.4 | 1.4 | 0.4 | · | 13.7 | |
| P / Cash Flow | · | -15.5 | · | · | · | -2.5 | · | · | · | -10.0 | · | · | · | -1.1 | · | · | |
| Earnings Yield | -23.8% | -42.3% | · | -137.1% | -88.9% | -107.3% | · | -39.0% | -21.7% | -14.9% | · | -23.6% | -50.3% | -416.9% | · | -220.5% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $4M | $7M | $3M | $4M | $1M |
| Operating Margin % | -363.4% | -168.7% | -440.4% | -332.2% | · |
| Net Income | $-12M | $-11M | $-8M | $-30M | $-42M |
| Diluted EPS | $-0.79 | $-1.19 | $-0.94 | $-3.58 | $-5.47 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 8.4 | 6.4 | 5.6 | 2.1 | 3.6 |
| Quick Ratio | 7.1 | 5.5 | 4.9 | 1.5 | 3.3 |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 36 filers · $6.3M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
36
Value held
$6.3M
New positions
4
Exited positions
4
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 4 (-3 vs prior Q) | 4 (-3 vs prior Q) | 6 (0 vs prior Q) | 7 (-1 vs prior Q) | +67K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| NEA Management Company, LLC | $2,389,747 | 1,625,678 | 37.89% | Shares |
| Blue Owl Capital Holdings LP | $814,748 | 554,250 | 12.92% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $626,468 | 426,169 | 9.93% | Shares |
| VANGUARD GROUP INC | $515,651 | 346,074 | 8.18% | Shares |
| Aisling Capital Management LP | $478,293 | 325,370 | 7.58% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $366,652 | 249,423 | 5.81% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $205,558 | 139,816 | 3.26% | Shares |
| OSAIC HOLDINGS, INC. | $165,590 | 112,649 | 2.63% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $128,285 | 87,269 | 2.03% | Shares |
| LPL Financial LLC | $122,226 | 83,147 | 1.94% | Shares |
| TWO SIGMA INVESTMENTS, LP | $88,495 | 60,201 | 1.40% | Shares |
| Concurrent Investment Advisors, LLC | $72,720 | 67,963 | 1.15% | Shares |
| XTX Topco Ltd | $66,675 | 45,357 | 1.06% | Shares |
| NORTHERN TRUST CORP | $50,905 | 34,629 | 0.81% | Shares |
| CITADEL ADVISORS LLC | $47,800 | 32,517 | 0.76% | Shares |
| STATE STREET CORP | $30,794 | 20,948 | 0.49% | Shares |
| Invst, LLC | $26,460 | 18,000 | 0.42% | Shares |
| Creative Planning | $25,449 | 17,312 | 0.40% | Shares |
| JANE STREET GROUP, LLC | $24,743 | 16,832 | 0.39% | Shares |
| Ashton Thomas Private Wealth, LLC | $24,108 | 16,400 | 0.38% | Shares |
| FIFTH THIRD BANCORP | $14,700 | 10,000 | 0.23% | Shares |
| UBS Group AG | $11,981 | 8,150 | 0.19% | Shares |
| Vanguard Global Advisers, LLC | $3,693 | 2,512 | 0.06% | Shares |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $2,900 | 2,000 | 0.05% | Shares |
| Tower Research Capital LLC (TRC) | $1,191 | 810 | 0.02% | Shares |
| WELLS FARGO & COMPANY/MN | $341 | 232 | 0.01% | Shares |
| GROUP ONE TRADING LLC | $262 | 178 | 0.00% | Shares |
| SIGNATUREFD, LLC | $244 | 228 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $216 | 202 | 0.00% | Shares |
| BARCLAYS PLC | $93 | 63 | 0.00% | Shares |
| Hilltop National Bank | $78 | 73 | 0.00% | Shares |
| JPMORGAN CHASE & CO | $34 | 23 | 0.00% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $34 | 23 | 0.00% | Shares |
| Virtu Financial LLC | $17 | 11,574 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $13 | 9 | 0.00% | Shares |
| MORGAN STANLEY | $2 | 2 | 0.00% | Shares |
Activists & 5%+ owners 29 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×6 filings | Nov. 17, 2025 | 9.90% | Amendment | Passive investment | SEC |
| John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017 ×2 filings | Aug. 20, 2025 | 4.96% | Amendment | · | SEC |
| Aisling Capital IV, LP, Aisling Capital Partners IV, LP, Aisling Capital Partners IV LLC, Steve Elms, Andrew Schiff | March 3, 2023 | · | Initial filing | · | SEC |
| Ann Leen ×2 filings | March 24, 2021 | · | Initial filing | · | SEC |
| EASTERN CAPITAL LIMITED, PORTFOLIO SERVICES LTD., KENNETH B. DART ×14 filings | March 15, 2021 | · | Initial filing | · | SEC |
| Juan Vera | Feb. 14, 2019 | · | Initial filing | Passive investment | SEC |
| John Robert Wilson | Feb. 14, 2019 | · | Initial filing | Passive investment | SEC |
| OR | Oct. 19, 2018 | · | Initial filing | Passive investment | SEC |
| Iroquois Master Fund Ltd., Iroquois Capital Management, LLC, Richard Abbe, Kimberly Page | April 4, 2018 | · | Initial filing | Passive investment | SEC |
| Sailesh C Barchha (2) | Feb. 27, 2013 | · | Initial filing | · | SEC |
| Michael Gardner | Jan. 7, 2013 | · | Initial filing | Passive investment | SEC |
| WILFRED A. JEFFERIES | July 20, 2007 | · | Initial filing | Passive investment | SEC |
| Undisclosed reporting person | Oct. 3, 2002 | · | Initial filing | M&A / sale | SEC |
| Undisclosed reporting person | Aug. 20, 2002 | · | Initial filing | M&A / sale | SEC |
| Undisclosed reporting person, Undisclosed reporting person | July 26, 2002 | · | Initial filing | M&A / sale | SEC |
| Undisclosed reporting person | May 14, 2002 | · | Initial filing | · | SEC |
| Undisclosed reporting person | May 14, 2002 | · | Initial filing | · | SEC |
| Undisclosed reporting person | May 14, 2002 | · | Initial filing | · | SEC |
| Undisclosed reporting person | May 14, 2002 | · | Initial filing | · | SEC |
| Undisclosed reporting person | May 14, 2002 | · | Initial filing | · | SEC |
| Undisclosed reporting person | May 14, 2002 | · | Initial filing | · | SEC |
| Undisclosed reporting person | May 14, 2002 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Feb. 13, 2002 | · | Initial filing | · | SEC |
| Undisclosed reporting person | May 14, 2001 | · | Initial filing | · | SEC |
| Undisclosed reporting person | May 14, 2001 | · | Initial filing | · | SEC |
| Undisclosed reporting person | April 16, 2001 | · | Initial filing | · | SEC |
| Undisclosed reporting person | March 21, 2001 | · | Initial filing | · | SEC |
| Undisclosed reporting person | March 21, 2001 | · | Initial filing | · | SEC |
| Undisclosed reporting person | March 21, 2001 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 37 insiders · 14 officers · 18 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Juan Vera | Chief Executive Officer | Oct. 31, 2025 A | 2,671,845 | 0 | 0 | $0 |
| Peter L. Hoang | President and CEO | March 24, 2022 F | 483,286 | 0 | 0 | $0 |
| Ronald L Handford | President/CEO | Dec. 16, 2003 A | · | 0 | 0 | $0 |
| Anthony H. Kim | Chief Financial Officer | March 24, 2022 F | 114,436 | 0 | 0 | $0 |
| Tracy A Moore | Chief Financial Officer | Oct. 14, 2009 A | 500,000 | 0 | 0 | $0 |
| John N Bonfiglio | President and COO | March 9, 2017 A | 26,054 | 0 | 0 | $0 |
| Denis Corin | President | Feb. 17, 2012 J | 2,394,535 | 0 | 0 | $0 |
| Anna Szymanska | Vice President, Quality | Feb. 27, 2023 A | · | 0 | 0 | $0 |
| Nadia Agopyan | SVP, Regulatory Affairs | Feb. 27, 2023 A | · | 0 | 0 | $0 |
| Mythili Koneru | Chief Medical Officer | Feb. 27, 2023 A | · | 0 | 0 | $0 |
| Tsvetelina P Hoang | VP, Research and Development | Feb. 27, 2023 A | · | 0 | 0 | $0 |
| Michael Loiacono | Chief Accounting Officer | Feb. 27, 2023 A | · | 0 | 0 | $0 |
| Gerald Garrett | Vice President, Clinical Ops. | Feb. 17, 2022 A | · | 0 | 0 | $0 |
| Wilfred Jefferies | Chief Scientist Officer | Dec. 16, 2003 A | · | 0 | 0 | $0 |
| Katharine Knobil | Director | Nov. 17, 2025 A | · | 0 | 0 | $0 |
| Steve Elms | Director | Nov. 17, 2025 A | 325,370 | 0 | 0 | $0 |
| Kathryn Penkus Corzo | Director | Oct. 31, 2025 A | · | 0 | 0 | $0 |
| John Robert Wilson | Director | June 6, 2023 A | 7,812,008 | 0 | 0 | $0 |
| David Laskow-Pooley | Director | May 24, 2022 A | 55,223 | 0 | 0 | $0 |
| Frederick Gerald Wasserman | Director | June 8, 2021 A | 65,223 | 0 | 0 | $0 |
| Sherry Grisewood | Director | Oct. 16, 2018 A | 19,582 | 0 | 0 | $0 |
| Mark Reddish | Director | Oct. 16, 2018 A | 36,110 | 0 | 0 | $0 |
| Joshua Silverman | Director | Oct. 16, 2018 A | 17,221 | 0 | 0 | $0 |
| Glynn Wilson | Director | Oct. 9, 2018 M | 181,776 | 0 | 0 | $0 |
| Alan P Lindsay | Director | March 11, 2009 J | · | 0 | 0 | $0 |
| Carmen Chang | 10% owner | March 16, 2021 P | 10,714,285 | 0 | 0 | $0 |
| Mohamad Makhzoumi | 10% owner | March 16, 2021 P | 10,714,285 | 0 | 0 | $0 |
| Ali Behbahani | 10% owner | March 16, 2021 P | 10,714,285 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | 10% owner | March 16, 2021 P | 10,714,285 | 0 | 0 | $0 |
| Peter W. Sonsini | 10% owner | March 16, 2021 P | 10,714,285 | 0 | 0 | $0 |
| Paul Walker | 10% owner | March 16, 2021 P | 10,714,285 | 0 | 0 | $0 |
| Forest Baskett | 10% owner | March 16, 2021 P | 10,714,285 | 0 | 0 | $0 |
| Scott D. Sandell | 10% owner | March 16, 2021 P | 10,714,285 | 0 | 0 | $0 |
| Joshua Makower | 10% owner | March 16, 2021 P | 10,714,285 | 0 | 0 | $0 |
| Norman David Eansor | · | Nov. 17, 2025 A | 7,142 | 0 | 0 | $0 |
| Grant R Atkins | · | Dec. 16, 2003 A | · | 0 | 0 | $0 |
| GENEMAX CORP | · | Dec. 16, 2003 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
MRKR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$8.00
+733.2%
2 22.2%
Strong Buy
6 66.7%
Buy
1 11.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-10-21Mean target $7.87 +719.4%
← Below all targets
Current price $0.96
Low$5.60
Mean$7.87
High$10.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026